Wellgistics Health, Inc. (WGRX)
NASDAQ: WGRX · Real-Time Price · USD
0.6990
-0.0080 (-1.13%)
At close: Aug 13, 2025, 4:00 PM
0.7040
+0.0050 (0.72%)
Pre-market: Aug 14, 2025, 9:05 AM EDT

Regulus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22
43---
Enterprise Value
66---
Debt / Equity Ratio
5.723.71-0.12-
Asset Turnover
0.970.63--
Quick Ratio
0.140.130.12-
Current Ratio
0.360.400.12-
Return on Equity (ROE)
-2124.65%-357.65%--
Return on Assets (ROA)
-77.95%-13.32%--
Return on Capital (ROIC)
-152.86%-26.32%--
Buyback Yield / Dilution
--5.66%--
Updated Dec 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q